{"id":26647,"date":"2025-01-24T00:00:00","date_gmt":"2025-01-23T20:00:00","guid":{"rendered":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/"},"modified":"2025-02-03T15:08:12","modified_gmt":"2025-02-03T11:08:12","slug":"pharmeasy-planning-for-ipo-again-after-2-years-is-it-final","status":"publish","type":"post","link":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/","title":{"rendered":"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?"},"content":{"rendered":"\n<p>After 2 years of pulling back its IPO, Pharmeasy is in talks to relaunch its IPO. According to the <a href=\"https:\/\/economictimes.indiatimes.com\/tech\/startups\/pharmeasy-to-formally-discuss-ipo-plans-with-its-board-in-second-try\/articleshow\/117405538.cms?from=mdr\">Economic Times<\/a>, this is part of Pharmeasy&#8217;s renewed strategy aims to sustain financially by merging with its listed subsidiary, Thyrocare.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-will-pharmeasy-go-for-ipo\">Will PharmEasy go for IPO?<\/h2>\n\n\n\n<p>According to a source quoted by ET, Pharmeasy will present its IPO strategy in February next month. <strong>A noteworthy development is that the company plans to do a reverse merger with its listed subsidiary Thyrocare. <\/strong>The intention is to streamline operations &amp; appeal to public market investors.<\/p>\n\n\n\n<p>Not just Pharmeasy, but many Indian start-ups like Oyo &amp; Boat have followed the trend of re-starting IPO discussions after delaying due to market uncertainties. Leadership changes have led to a change in the company&#8217;s direction. <\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-pharmeasy-co-founders-resign\">Pharmeasy Co founders Resign<\/h2>\n\n\n\n<p><strong>Co-founders, Dhaval Shah, Dharmil Sheth, and Hardik Dedhia have stepped back as founders<\/strong> of Pharmeasy but remain on board for API Holdings and Thyrocare. Siddharth Shah continues to be the CEO of Pharmeasy.<\/p>\n\n\n\n<p>Pharmeasy&#8217;s financials and valuations have also been a concern.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-pharmeasy-made-significant-financial-adjustments\">Pharmeasy Made Significant Financial Adjustments <\/h2>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img decoding=\"async\" src=\"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/The-bar-below-describes-the-growth-of-our-business-during-2021-2-1024x1024.png\" alt=\"Pharmeasy Financial Performance\" class=\"wp-image-26430\" style=\"width:491px;height:auto\" \/><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li>PharmEasy\u2019s <strong>Revenue declined by 14.7%<\/strong> to Rs 5,664 crore in FY 24 from Rs 6,644 crore in FY23. This decline can be concerning.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Their <strong>primary revenue driver was medical sales<\/strong> contributing to Rs 5,008 crore, while lab testing and other services contributed to Rs 652 crore.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>At the same time, th<strong>e net loss was reduced by 50%<\/strong> from \u20b95,212 crore in FY 23 to \u20b92,533 crore in FY 24. This was due to operational cost-cutting measures and a reduction in goodwill impairment.<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Pharm easy&#8217;s <strong>total expenses also reduced from Rs 8,974 crore in FY23 to Rs 7,255 crore in FY24,<\/strong> signaling a tighter control over expenses.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p>Their financial performance can significantly impact pharmeasy pre ipo shares valuation.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-challenging-road-ahead-for-pharmeasy\">Challenging Road Ahead For Pharmeasy<\/h2>\n\n\n\n<p>Pharmeasy did a recapitalization in 2023 issuing the right shares. Investors like Manipal Group\u2019s Ranjan Pai, alongside Prosus Ventures and Temasek, participated in this round.<strong> The company\u2019s valuation plummeted by a staggering 92% and dropped from a peak of $4.8 billion to $458 million<\/strong>. These funds were primarily used for debt restructuring, laying the groundwork for Pharmeasy IPO.<\/p>\n\n\n\n<p>Pharmeasy may have a challenging road ahead as competitors like Tata 1mg, and Apollo 24 X 7 are leading the game. Ecom giant Flipkart has also entered this market. <strong>The recent strategic change is a significant effort to lead the Online Pharmacy sector facing high competition.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>After 2 years of pulling back its IPO, Pharmeasy is in talks to relaunch its IPO. According to the Economic Times, this is part of Pharmeasy&#8217;s renewed strategy aims to sustain financially by merging with its listed subsidiary, Thyrocare. Will PharmEasy go for IPO? According to a source quoted by ET, Pharmeasy will present its [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":26650,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_glsr_average":0,"_glsr_ranking":0,"_glsr_reviews":0,"footnotes":""},"categories":[1],"tags":[185],"class_list":["post-26647","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-pharmeasy"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.9 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pharmeasy Planning For IPO Again After 2 Years. Is It Final? - Stockify Fintech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?\" \/>\n<meta property=\"og:description\" content=\"After 2 years of pulling back its IPO, Pharmeasy is in talks to relaunch its IPO. According to the Economic Times, this is part of Pharmeasy&#8217;s renewed strategy aims to sustain financially by merging with its listed subsidiary, Thyrocare. Will PharmEasy go for IPO? According to a source quoted by ET, Pharmeasy will present its [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/\" \/>\n<meta property=\"og:site_name\" content=\"Stockify Fintech\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-23T20:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-03T11:08:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2240\" \/>\n\t<meta property=\"og:image:height\" content=\"1260\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Rahul Khatuwala\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rahul Khatuwala\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/\"},\"author\":{\"name\":\"Rahul Khatuwala\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#\\\/schema\\\/person\\\/848d25b83f7e6d3b6b836bde43ba675c\"},\"headline\":\"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?\",\"datePublished\":\"2025-01-23T20:00:00+00:00\",\"dateModified\":\"2025-02-03T11:08:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/\"},\"wordCount\":397,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Blog-Banner-for-Website-Content-11-3.png\",\"keywords\":[\"Pharmeasy\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/\",\"url\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/\",\"name\":\"Pharmeasy Planning For IPO Again After 2 Years. Is It Final? - Stockify Fintech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Blog-Banner-for-Website-Content-11-3.png\",\"datePublished\":\"2025-01-23T20:00:00+00:00\",\"dateModified\":\"2025-02-03T11:08:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#primaryimage\",\"url\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Blog-Banner-for-Website-Content-11-3.png\",\"contentUrl\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/Blog-Banner-for-Website-Content-11-3.png\",\"width\":2240,\"height\":1260},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#website\",\"url\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/\",\"name\":\"Stockify Fintech\",\"description\":\"Invest Early\",\"publisher\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#organization\",\"name\":\"Stockify Fintech\",\"url\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/cropped-cropped-stockify-wealth.png\",\"contentUrl\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/cropped-cropped-stockify-wealth.png\",\"width\":800,\"height\":248,\"caption\":\"Stockify Fintech\"},\"image\":{\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/#\\\/schema\\\/person\\\/848d25b83f7e6d3b6b836bde43ba675c\",\"name\":\"Rahul Khatuwala\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/62aeea639442a9d5e3d2c23bef7ca7a39f06b970cada816700561f18b3b13772?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/62aeea639442a9d5e3d2c23bef7ca7a39f06b970cada816700561f18b3b13772?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/62aeea639442a9d5e3d2c23bef7ca7a39f06b970cada816700561f18b3b13772?s=96&d=mm&r=g\",\"caption\":\"Rahul Khatuwala\"},\"description\":\"Chartered Accountant | Ex Wipro | Founder Finaco | Co-Founder Stockify\",\"sameAs\":[\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\"],\"url\":\"https:\\\/\\\/tester-hub.com\\\/stockifyfintech\\\/blog\\\/author\\\/rahul-khatuwala\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharmeasy Planning For IPO Again After 2 Years. Is It Final? - Stockify Fintech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?","og_description":"After 2 years of pulling back its IPO, Pharmeasy is in talks to relaunch its IPO. According to the Economic Times, this is part of Pharmeasy&#8217;s renewed strategy aims to sustain financially by merging with its listed subsidiary, Thyrocare. Will PharmEasy go for IPO? According to a source quoted by ET, Pharmeasy will present its [&hellip;]","og_url":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/","og_site_name":"Stockify Fintech","article_published_time":"2025-01-23T20:00:00+00:00","article_modified_time":"2025-02-03T11:08:12+00:00","og_image":[{"width":2240,"height":1260,"url":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png","type":"image\/png"}],"author":"Rahul Khatuwala","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Rahul Khatuwala","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#article","isPartOf":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/"},"author":{"name":"Rahul Khatuwala","@id":"https:\/\/tester-hub.com\/stockifyfintech\/#\/schema\/person\/848d25b83f7e6d3b6b836bde43ba675c"},"headline":"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?","datePublished":"2025-01-23T20:00:00+00:00","dateModified":"2025-02-03T11:08:12+00:00","mainEntityOfPage":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/"},"wordCount":397,"commentCount":0,"publisher":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/#organization"},"image":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#primaryimage"},"thumbnailUrl":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png","keywords":["Pharmeasy"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/","url":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/","name":"Pharmeasy Planning For IPO Again After 2 Years. Is It Final? - Stockify Fintech","isPartOf":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#primaryimage"},"image":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#primaryimage"},"thumbnailUrl":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png","datePublished":"2025-01-23T20:00:00+00:00","dateModified":"2025-02-03T11:08:12+00:00","breadcrumb":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#primaryimage","url":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png","contentUrl":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png","width":2240,"height":1260},{"@type":"BreadcrumbList","@id":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/pharmeasy-planning-for-ipo-again-after-2-years-is-it-final\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tester-hub.com\/stockifyfintech\/"},{"@type":"ListItem","position":2,"name":"Pharmeasy Planning For IPO Again After 2 Years. Is It Final?"}]},{"@type":"WebSite","@id":"https:\/\/tester-hub.com\/stockifyfintech\/#website","url":"https:\/\/tester-hub.com\/stockifyfintech\/","name":"Stockify Fintech","description":"Invest Early","publisher":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tester-hub.com\/stockifyfintech\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/tester-hub.com\/stockifyfintech\/#organization","name":"Stockify Fintech","url":"https:\/\/tester-hub.com\/stockifyfintech\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tester-hub.com\/stockifyfintech\/#\/schema\/logo\/image\/","url":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2023\/01\/cropped-cropped-stockify-wealth.png","contentUrl":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2023\/01\/cropped-cropped-stockify-wealth.png","width":800,"height":248,"caption":"Stockify Fintech"},"image":{"@id":"https:\/\/tester-hub.com\/stockifyfintech\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/tester-hub.com\/stockifyfintech\/#\/schema\/person\/848d25b83f7e6d3b6b836bde43ba675c","name":"Rahul Khatuwala","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/62aeea639442a9d5e3d2c23bef7ca7a39f06b970cada816700561f18b3b13772?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/62aeea639442a9d5e3d2c23bef7ca7a39f06b970cada816700561f18b3b13772?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/62aeea639442a9d5e3d2c23bef7ca7a39f06b970cada816700561f18b3b13772?s=96&d=mm&r=g","caption":"Rahul Khatuwala"},"description":"Chartered Accountant | Ex Wipro | Founder Finaco | Co-Founder Stockify","sameAs":["https:\/\/tester-hub.com\/stockifyfintech"],"url":"https:\/\/tester-hub.com\/stockifyfintech\/blog\/author\/rahul-khatuwala\/"}]}},"jetpack_featured_media_url":"https:\/\/tester-hub.com\/stockifyfintech\/wp-content\/uploads\/2025\/02\/Blog-Banner-for-Website-Content-11-3.png","_links":{"self":[{"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/posts\/26647","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/comments?post=26647"}],"version-history":[{"count":0,"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/posts\/26647\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/media\/26650"}],"wp:attachment":[{"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/media?parent=26647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/categories?post=26647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tester-hub.com\/stockifyfintech\/wp-json\/wp\/v2\/tags?post=26647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}